Kay Herbrig

1.0k total citations
18 papers, 809 citations indexed

About

Kay Herbrig is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Kay Herbrig has authored 18 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Physiology. Recurrent topics in Kay Herbrig's work include Angiogenesis and VEGF in Cancer (7 papers), Nitric Oxide and Endothelin Effects (4 papers) and Lymphatic System and Diseases (3 papers). Kay Herbrig is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Nitric Oxide and Endothelin Effects (4 papers) and Lymphatic System and Diseases (3 papers). Kay Herbrig collaborates with scholars based in Germany and United States. Kay Herbrig's co-authors include Frank Pistrosch, Jens Passauer, Peter Groß, Sabine Fischer, Uta Oelschlaegel, Sarah Foerster, Stefan Richter, Andrea Wagner, Gunnar Wichmann and Susanne Richter and has published in prestigious journals such as Diabetes, Kidney International and The American Journal of Medicine.

In The Last Decade

Kay Herbrig

17 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Herbrig Germany 14 421 185 166 136 133 18 809
Nélida Eleno Spain 19 444 1.1× 106 0.6× 217 1.3× 155 1.1× 195 1.5× 35 1.1k
Gisselle Carvajal Spain 10 551 1.3× 233 1.3× 181 1.1× 69 0.5× 126 0.9× 11 1.1k
Sung Kwang Park South Korea 11 417 1.0× 143 0.8× 74 0.4× 139 1.0× 87 0.7× 22 861
Ryuichiro Murakami Japan 19 302 0.7× 271 1.5× 81 0.5× 70 0.5× 108 0.8× 33 974
Bishoy Rizkalla Australia 8 304 0.7× 166 0.9× 268 1.6× 67 0.5× 86 0.6× 15 891
Valentina Câmpean Germany 19 521 1.2× 136 0.7× 279 1.7× 81 0.6× 218 1.6× 30 1.3k
Kumiko Torisu Japan 14 302 0.7× 102 0.6× 197 1.2× 77 0.6× 72 0.5× 44 837
Ana B. Rodríguez-Peña Spain 15 338 0.8× 112 0.6× 321 1.9× 57 0.4× 153 1.2× 17 807
Sherif Youssef Australia 8 265 0.6× 207 1.1× 316 1.9× 57 0.4× 75 0.6× 14 963
Dimitria Vranes Australia 7 302 0.7× 115 0.6× 257 1.5× 61 0.4× 68 0.5× 10 800

Countries citing papers authored by Kay Herbrig

Since Specialization
Citations

This map shows the geographic impact of Kay Herbrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Herbrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Herbrig more than expected).

Fields of papers citing papers by Kay Herbrig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Herbrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Herbrig. The network helps show where Kay Herbrig may publish in the future.

Co-authorship network of co-authors of Kay Herbrig

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Herbrig. A scholar is included among the top collaborators of Kay Herbrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Herbrig. Kay Herbrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schirutschke, Holger, Bertram Schmitt, J.-C. Schewe, et al.. (2012). Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy. International Urology and Nephrology. 45(1). 229–232. 24 indexed citations
2.
Pistrosch, Frank, et al.. (2012). Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt Nephropathy. Hormone and Metabolic Research. 44(12). 914–918. 30 indexed citations
3.
Büssemaker, Eckhart, Kay Herbrig, Frank Pistrosch, Carrie A. Palm, & Jens Passauer. (2009). Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients. Atherosclerosis. 207(2). 567–572. 14 indexed citations
4.
Passauer, Jens, Kay Herbrig, Sven Fischer, Stefan R. Bornstein, & Ulrich Julius. (2009). A single lipid apheresis does not modulate pulse wave reflection in hypercholesterolemic patients. Atherosclerosis Supplements. 10(5). 44–48. 2 indexed citations
5.
Pistrosch, Frank, et al.. (2008). New onset of alopecia in a young woman with end-stage renal disease. Clinical Kidney Journal. 1(3). 162–163.
6.
Pistrosch, Frank, Sarah Förster, Kay Herbrig, et al.. (2007). Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H541–H547. 38 indexed citations
7.
Herbrig, Kay, Frank Pistrosch, Sarah Foerster, & Peter Groß. (2006). Endothelial Progenitor Cells in Chronic Renal Insufficiency. Kidney & Blood Pressure Research. 29(1). 24–31. 30 indexed citations
8.
Pistrosch, Frank, et al.. (2006). Vasopressin Antagonists as Aquaretic Agents for the Treatment of Hyponatremia. The American Journal of Medicine. 119(7). S87–S92. 38 indexed citations
9.
Herbrig, Kay, Uta Oelschlaegel, Frank Pistrosch, et al.. (2006). Kidney Transplantation Substantially Improves Endothelial Progenitor Cell Dysfunction in Patients with End-Stage Renal Disease. American Journal of Transplantation. 6(12). 2922–2928. 36 indexed citations
10.
Pistrosch, Frank, Kay Herbrig, Uta Oelschlaegel, et al.. (2005). PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis. 183(1). 163–167. 125 indexed citations
11.
Passauer, Jens, Frank Pistrosch, Kay Herbrig, et al.. (2005). Nitric oxide– and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9. Kidney International. 67(5). 1907–1912. 18 indexed citations
12.
Herbrig, Kay, et al.. (2005). Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Annals of the Rheumatic Diseases. 65(2). 157–163. 118 indexed citations
13.
Passauer, Jens, et al.. (2005). Reduced Agonist-Induced Endothelium-Dependent Vasodilation in Uremia Is Attributable to an Impairment of Vascular Nitric Oxide. Journal of the American Society of Nephrology. 16(4). 959–965. 79 indexed citations
15.
Herbrig, Kay, et al.. (2004). Role of endothelial progenitor cells in cardiovascular pathology.. PubMed. 49. 174–7. 8 indexed citations
16.
Herbrig, Kay, Frank Pistrosch, Uta Oelschlaegel, et al.. (2004). Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. American Journal of Kidney Diseases. 44(5). 840–849. 77 indexed citations
17.
Herbrig, Kay, Frank Pistrosch, Uta Oelschlaegel, et al.. (2004). Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. American Journal of Kidney Diseases. 44(5). 840–849. 40 indexed citations
18.
Herbrig, Kay, et al.. (2003). Dry cough in a CAPD patient. Nephrology Dialysis Transplantation. 18(5). 1027–1029. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026